Pharmconsul Private Limited - Company Profile

It is a business outsourcing private limited company based in Tirumalagiri, Telangana, India, established in 2019.
2019 Tirumalagiri, Telangana, India Active
Last Updated:
Access Report
About Pharmconsul Private Limited

Pharmconsul Private Limited, a active private limited company, was established on 10 June 2019 in Tirumalagiri, Telangana, India. Engaging in business & it consulting within the professional, scientific and technical sector, it holds CIN: U72200TG2019PTC133251. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.30 M.

Its leadership includes Harish Rachamalla (Director), Shailesh Morishetty (Director). Past directors included Yeshwanth Morishetty. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.66,67, Balaji Nagar, Opp. Prerana Hospital, Above Heritage Supermarket, Kukatpally, Tirumalagiri, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U72200TG2019PTC133251

  • Registration Number

    133251

  • Incorporation Date

    10 June 2019

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 23.01%
  • Profit Growth **** 5.03%
  • Ebitda **** 10.20%
  • Net Worth 62.63%
  • Total Assets **** 25.38%
Company report

Pharmconsul Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pharmconsul Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pharmconsul Private Limited?
Current Directors
Name Designation Appointment Date Status
Harish Rachamalla Director 08 Aug 2022 Current
Shailesh Morishetty Director 10 Jun 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pharmconsul.

Pharmconsul Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.01% increase. The company also saw a slight improvement in profitability, with a 5.03% increase in profit. The company's net worth Soared by an impressive increase of 62.63%.

Pharmconsul revenue growth over time
Pharmconsul profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 23.01%
*******
*******
*******
*******
Revenue from Operations
*******
 23.01%
*******
*******
*******
*******
Total Assets
*******
 25.38%
*******
*******
*******
*******
Profit or Loss
*******
 5.03%
*******
*******
*******
*******
Net Worth
*******
 62.63%
*******
*******
*******
*******
EBITDA
*******
 10.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pharmconsul?

In 2021, Pharmconsul had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pharmconsul?

Unlock and access historical data on people associated with Pharmconsul, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pharmconsul, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmconsul's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pharmconsul
Recent Activity within the Organization
  • Annual General Meeting

    The activity Pharmconsul Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Pharmconsul Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Harish Rachamalla was appointed as a Director was appointed as a Director on 08 Aug 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Shailesh Morishetty was appointed as a Director was appointed as a Director on 10 Jun 2019 & has been associated with this company since 6 years 8 months . was documented.

  • Company Incorporation

    Progress on Pharmconsul Private Limited was registered on 10 Jun 2019 with Roc Hyderabad & aged 6 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pharmconsul Private Limited?

The CIN of Pharmconsul Private Limited is U72200TG2019PTC133251.

Where is Pharmconsul Private Limited headquartered?

Pharmconsul Private Limited is headquartered at Plot No.66,67, Balaji Nagar, Opp. Prerana Hospital, Above Heritage Supermarket, Kukatpally, Tirumalagiri, Telangana, 500072.

When was Pharmconsul Private Limited incorporated?

Pharmconsul Private Limited was incorporated on 10 June 2019.

Who are the current directors of Pharmconsul Private Limited?

The current directors of Pharmconsul Private Limited are

What is the primary industry of Pharmconsul Private Limited?

The primary industry of Pharmconsul Private Limited is Professional, Scientific And Technical.

Is Pharmconsul Private Limited a listed company?

Pharmconsul Private Limited is unlisted.

What is the capital structure of Pharmconsul Private Limited?

The authorized capital of Pharmconsul Private Limited is ₹3.00 M, and the paid-up capital is ₹0.30 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available